Literature DB >> 1385482

Amyloid in prostatic corpora amylacea.

P A Cross1, C J Bartley, J McClure.   

Abstract

AIM: To determine the presence and nature of amyloid in prostatic corpora amylacea using immunohistological studies.
METHODS: Prostatic tissue from 18 transurethral and two open resection specimens was studied. Paraffin wax embedded tissue sections were stained with haematoxylin and eosin and the alkaline Congo red method with and without previous treatment with potassium permanganate. Sections were also stained with antibodies to amyloid A, beta 2 microglobulin, lambda and kappa light chains, prealbumin IgA, G, M, S100 protein, prostatic specific antigen, amyloid P component and CAM 5.2 (control and blocking studies were performed).
RESULTS: The prostatic corpora amylacea universally showed the presence of amyloid. In all instances this contained beta 2 microglobulin.
CONCLUSION: Prostatic corpora amylacea represents a localised amyloidosis of beta 2 microglobulin origin that is unrelated to chronic renal failure and haemodialysis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1385482      PMCID: PMC495061          DOI: 10.1136/jcp.45.10.894

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  18 in total

1.  Cytochemical observations on the corpora amylacea of the human prostate gland.

Authors:  A R SEAMAN
Journal:  J Urol       Date:  1956-07       Impact factor: 7.450

2.  Prostatic corpora amylacea.

Authors:  G C PRATHER; D SKINNER
Journal:  J Urol       Date:  1956-07       Impact factor: 7.450

3.  Apoptotic amyloid: a study on prostatic amyloidosis with particular reference to corpora amylacea.

Authors:  S Battaglia; G Barbolini; A R Botticelli; G P Trentini
Journal:  Appl Pathol       Date:  1985

4.  Amyloid deposition in the prostate.

Authors:  S K Wilson; R D Buchanan; W J Stone; R K Rhamy
Journal:  J Urol       Date:  1973-09       Impact factor: 7.450

5.  Prostatic corpora amylacea. A study with the electron microscope and electron probe.

Authors:  A J Marx; J F Moskal; B Gueft
Journal:  Arch Pathol       Date:  1965-11

Review 6.  Beta 2-microglobulin: an old molecule assumes a new look.

Authors:  R P Messner
Journal:  J Lab Clin Med       Date:  1984-08

7.  Potassium permanganate reaction in amyloidosis. A histologic method to assist in differentiating forms of this disease.

Authors:  J R Wright; E Calkins; R L Humphrey
Journal:  Lab Invest       Date:  1977-03       Impact factor: 5.662

8.  Histochemical and immunohistochemical characterization of amyloid associated with chronic hemodialysis as beta 2-microglobulin.

Authors:  T Shirahama; M Skinner; A S Cohen; F Gejyo; M Arakawa; M Suzuki; Y Hirasawa
Journal:  Lab Invest       Date:  1985-12       Impact factor: 5.662

9.  Serum beta2-microglobulin in hemodialyzed patients.

Authors:  C Vincent; J P Revillard; M Galland; J Traeger
Journal:  Nephron       Date:  1978       Impact factor: 2.847

10.  In vitro formation of amyloid fibrils from intact beta 2-microglobulin.

Authors:  L H Connors; T Shirahama; M Skinner; A Fenves; A S Cohen
Journal:  Biochem Biophys Res Commun       Date:  1985-09-30       Impact factor: 3.575

View more
  7 in total

1.  Characterization of corpora amylacea glycoconjugates in normal and hyperplastic glands of human prostate.

Authors:  Eva Morales; Luis A Polo; Luis M Pastor; Luis Santamaría; Alfonso Calvo; Adelina Zuasti; Concepción Ferrer
Journal:  J Mol Histol       Date:  2005-05       Impact factor: 2.611

2.  Infections and inflammation in prostate cancer.

Authors:  Karen S Sfanos; William B Isaacs; Angelo M De Marzo
Journal:  Am J Clin Exp Urol       Date:  2013-12-25

3.  Acute inflammatory proteins constitute the organic matrix of prostatic corpora amylacea and calculi in men with prostate cancer.

Authors:  Karen S Sfanos; Brice A Wilson; Angelo M De Marzo; William B Isaacs
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-06       Impact factor: 11.205

4.  Incidental prostate ¹⁸F-FDG uptake without calcification indicates the possibility of prostate cancer.

Authors:  Hiroko Seino; Shuichi Ono; Hiroyuki Miura; Satoko Morohashi; Yunyan Wu; Fumiyasu Tsushima; Yoshihiro Takai; Hiroshi Kijima
Journal:  Oncol Rep       Date:  2014-02-04       Impact factor: 3.906

Review 5.  The Etiology and Pathophysiology Genesis of Benign Prostatic Hyperplasia and Prostate Cancer: A New Perspective.

Authors:  Teow J Phua
Journal:  Medicines (Basel)       Date:  2021-06-11

6.  Amyloid formation by the pro-inflammatory S100A8/A9 proteins in the ageing prostate.

Authors:  Kiran Yanamandra; Oleg Alexeyev; Vladimir Zamotin; Vaibhav Srivastava; Andrei Shchukarev; Ann-Christin Brorsson; Gian Gaetano Tartaglia; Thomas Vogl; Rakez Kayed; Gunnar Wingsle; Jan Olsson; Christopher M Dobson; Anders Bergh; Fredrik Elgh; Ludmilla A Morozova-Roche
Journal:  PLoS One       Date:  2009-05-15       Impact factor: 3.240

7.  Prostatic calcifications: Quantifying occurrence, radiodensity, and spatial distribution in prostate cancer patients.

Authors:  Saurabh Singh; Eleanor Martin; Henry F J Tregidgo; Bradley Treeby; Steve Bandula
Journal:  Urol Oncol       Date:  2021-01-20       Impact factor: 3.498

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.